Skip to main content
. 2023 Jun 14;14:1145481. doi: 10.3389/fimmu.2023.1145481

Figure 7.

Figure 7

Genome-based and ICD-TDGs-based drug sensitivity prediction. (A) Drug sensitivity prediction, including epirubicin (EPI), cyclophosphamide (CTX), paclitaxel (PTX), docetaxel (DTX) and tamoxifen (TAM), in BRCA with TCGA data, amongst which green background represented genome-based drug sensitivity prediction while yellow background represented ICD-TDGs-based drug sensitivity prediction. (B) Drug sensitivity prediction in whole BRCA cohorts, in which data from GEO (GSE51561, GES20685, GSE20711, GSE25066, GSE29431, GSE613041); (C) Drug sensitivity prediction in TNBC cohorts, in which data from GEO (GSE18864, GES58812, GSE76124, GSE83937, GSE975001).